Columbia Sportswear vs Ermenegildo Zegna
COLM and ZGN side by side, both in apparel and other finished products made from fabrics and similar materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How COLM and ZGN compare
Columbia Sportswear grew revenue faster over the last twelve months (0.07% versus −1.5% for Ermenegildo Zegna).
Columbia Sportswear keeps more of each dollar of sales as profit, with a net margin of 7.0% compared with 5.1% at Ermenegildo Zegna.
Columbia Sportswear pays a dividend yielding 1.6%; Ermenegildo Zegna does not pay one.
Columbia Sportswear scores higher on the StockData Score (19 against 10 for Ermenegildo Zegna), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | COLM | ZGN |
|---|---|---|
| Size and price | ||
| Market cap | $3.8B | – |
| Share price | $73.47 | $13.80 |
| Change, 1 year | 38.5% | 32.7% |
| Change, 5 years | −28.9% | 37.0% |
| Beta (5Y) | 0.74 | 0.82 |
| Employees | 9,620 | 300 |
| StockData Score | ||
| Total score | 19 (better) | 10 |
| Valuation score | 4 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 4 | 4 |
| Health score | 6 (better) | 4 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 16.1× | – |
| P/S | 1.1× | – |
| P/B | 2.3× | – |
| EV/EBITDA | 9.9× | – |
| P/FCF | 13.7× | – |
| FCF yield | 7.3% | – |
| Fair value | $78.72 | – |
| Margin of safety | 6.7% | – |
| Growth | ||
| Revenue growth (TTM) | 0.07% (better) | −1.5% |
| Revenue growth, 5Y average | 6.3% | 13.6% (better) |
| Net income growth (TTM) | 27.9% (better) | 27.9% |
| EPS growth (TTM) | 37.8% (better) | 26.7% |
| EPS growth, 5Y average | 14.9% | – |
| Profitability | ||
| Gross margin | 52.1% | 67.5% (better) |
| Operating margin | 8.7% (better) | 7.3% |
| Net margin | 7.0% (better) | 5.1% |
| FCF margin | 8.0% | 13.3% (better) |
| Return on equity | 14.5% (better) | 10.3% |
| Return on invested capital | 16.0% (better) | 10.3% |
| Financial health | ||
| Debt / equity | 0.00 | 0.22 (better) |
| Net debt / EBITDA | – | −0.00 |
| Interest coverage | – | 2.8× |
| Current ratio | 2.60 (better) | 1.47 |
| Altman Z-score | 4.87 | – |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.6% | – |
| Payout ratio | 26.1% | 30.9% |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 35.8% | – |
| Buyback yield | 6.1% | – |
| Shareholder yield | 7.7% | – |
| Ownership | ||
| Held by institutions | 51.1% | 17.8% |
| Held by insiders | 52.7% | – |
| Insider net buying, 12 months | −$3.0M | −$814K (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 18.9% | – |
Go deeper
- COLM stock overview
- COLM income statement
- COLM valuation and score
- ZGN stock overview
- ZGN income statement
- ZGN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.